304 related articles for article (PubMed ID: 33806279)
1. The Influence of Smoking Status on Exhaled Breath Profiles in Asthma and COPD Patients.
Principe S; van Bragt JJMH; Longo C; de Vries R; Sterk PJ; Scichilone N; Vijverberg SJH; Maitland-van der Zee AH
Molecules; 2021 Mar; 26(5):. PubMed ID: 33806279
[TBL] [Abstract][Full Text] [Related]
2. Differentiating interstitial lung diseases from other respiratory diseases using electronic nose technology.
van der Sar IG; Wijsenbeek MS; Braunstahl GJ; Loekabino JO; Dingemans AC; In 't Veen JCCM; Moor CC
Respir Res; 2023 Nov; 24(1):271. PubMed ID: 37932795
[TBL] [Abstract][Full Text] [Related]
3. Integration of electronic nose technology with spirometry: validation of a new approach for exhaled breath analysis.
de Vries R; Brinkman P; van der Schee MP; Fens N; Dijkers E; Bootsma SK; de Jongh FH; Sterk PJ
J Breath Res; 2015 Oct; 9(4):046001. PubMed ID: 26469298
[TBL] [Abstract][Full Text] [Related]
4. Prospective Detection of Early Lung Cancer in Patients With COPD in Regular Care by Electronic Nose Analysis of Exhaled Breath.
de Vries R; Farzan N; Fabius T; De Jongh FHC; Jak PMC; Haarman EG; Snoey E; In 't Veen JCCM; Dagelet YWF; Maitland-Van Der Zee AH; Lucas A; Van Den Heuvel MM; Wolf-Lansdorf M; Muller M; Baas P; Sterk PJ
Chest; 2023 Nov; 164(5):1315-1324. PubMed ID: 37209772
[TBL] [Abstract][Full Text] [Related]
5. Ultrafast gas chromatography coupled to electronic nose to identify volatile biomarkers in exhaled breath from chronic obstructive pulmonary disease patients: A pilot study.
Rodríguez-Aguilar M; Ramírez-García S; Ilizaliturri-Hernández C; Gómez-Gómez A; Van-Brussel E; Díaz-Barriga F; Medellín-Garibay S; Flores-Ramírez R
Biomed Chromatogr; 2019 Dec; 33(12):e4684. PubMed ID: 31423612
[TBL] [Abstract][Full Text] [Related]
6. Exhaled breath profiling enables discrimination of chronic obstructive pulmonary disease and asthma.
Fens N; Zwinderman AH; van der Schee MP; de Nijs SB; Dijkers E; Roldaan AC; Cheung D; Bel EH; Sterk PJ
Am J Respir Crit Care Med; 2009 Dec; 180(11):1076-82. PubMed ID: 19713445
[TBL] [Abstract][Full Text] [Related]
7. Exhaled air molecular profiling in relation to inflammatory subtype and activity in COPD.
Fens N; de Nijs SB; Peters S; Dekker T; Knobel HH; Vink TJ; Willard NP; Zwinderman AH; Krouwels FH; Janssen HG; Lutter R; Sterk PJ
Eur Respir J; 2011 Dec; 38(6):1301-9. PubMed ID: 21700610
[TBL] [Abstract][Full Text] [Related]
8. External validation of exhaled breath profiling using an electronic nose in the discrimination of asthma with fixed airways obstruction and chronic obstructive pulmonary disease.
Fens N; Roldaan AC; van der Schee MP; Boksem RJ; Zwinderman AH; Bel EH; Sterk PJ
Clin Exp Allergy; 2011 Oct; 41(10):1371-8. PubMed ID: 21732998
[TBL] [Abstract][Full Text] [Related]
9. Breath profiles by electronic nose correlate with systemic markers but not ozone response.
Biller H; Holz O; Windt H; Koch W; Müller M; Jörres RA; Krug N; Hohlfeld JM
Respir Med; 2011 Sep; 105(9):1352-63. PubMed ID: 21439804
[TBL] [Abstract][Full Text] [Related]
10. Exhaled breath profiles in the monitoring of loss of control and clinical recovery in asthma.
Brinkman P; van de Pol MA; Gerritsen MG; Bos LD; Dekker T; Smids BS; Sinha A; Majoor CJ; Sneeboer MM; Knobel HH; Vink TJ; de Jongh FH; Lutter R; Sterk PJ; Fens N
Clin Exp Allergy; 2017 Sep; 47(9):1159-1169. PubMed ID: 28626990
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic Performance of Electronic Nose Technology in Sarcoidosis.
van der Sar IG; Moor CC; Oppenheimer JC; Luijendijk ML; van Daele PLA; Maitland-van der Zee AH; Brinkman P; Wijsenbeek MS
Chest; 2022 Mar; 161(3):738-747. PubMed ID: 34756945
[TBL] [Abstract][Full Text] [Related]
12. Exhaled Breath Profiles Before, During and After Exacerbation of COPD: A Prospective Follow-Up Study.
van Velzen P; Brinkman P; Knobel HH; van den Berg JWK; Jonkers RE; Loijmans RJ; Prins JM; Sterk PJ
COPD; 2019 Dec; 16(5-6):330-337. PubMed ID: 31588813
[TBL] [Abstract][Full Text] [Related]
13. Clinical and inflammatory phenotyping by breathomics in chronic airway diseases irrespective of the diagnostic label.
de Vries R; Dagelet YWF; Spoor P; Snoey E; Jak PMC; Brinkman P; Dijkers E; Bootsma SK; Elskamp F; de Jongh FHC; Haarman EG; In 't Veen JCCM; Maitland-van der Zee AH; Sterk PJ
Eur Respir J; 2018 Jan; 51(1):. PubMed ID: 29326334
[TBL] [Abstract][Full Text] [Related]
14. Exhaled breath analysis by use of eNose technology: a novel diagnostic tool for interstitial lung disease.
Moor CC; Oppenheimer JC; Nakshbandi G; Aerts JGJV; Brinkman P; Maitland-van der Zee AH; Wijsenbeek MS
Eur Respir J; 2021 Jan; 57(1):. PubMed ID: 32732331
[TBL] [Abstract][Full Text] [Related]
15. Exhaled Metabolite Patterns to Identify Recent Asthma Exacerbations.
van Bragt JJMH; Principe S; Hashimoto S; Versteeg DN; Brinkman P; Vijverberg SJH; Weersink EJM; Scichilone N; Maitland-van der Zee AH
Metabolites; 2021 Dec; 11(12):. PubMed ID: 34940630
[TBL] [Abstract][Full Text] [Related]
16. Effect of transportation and storage using sorbent tubes of exhaled breath samples on diagnostic accuracy of electronic nose analysis.
van der Schee MP; Fens N; Brinkman P; Bos LD; Angelo MD; Nijsen TM; Raabe R; Knobel HH; Vink TJ; Sterk PJ
J Breath Res; 2013 Mar; 7(1):016002. PubMed ID: 23257711
[TBL] [Abstract][Full Text] [Related]
17. A dual center study to compare breath volatile organic compounds from smokers and non-smokers with and without COPD.
Gaida A; Holz O; Nell C; Schuchardt S; Lavae-Mokhtari B; Kruse L; Boas U; Langejuergen J; Allers M; Zimmermann S; Vogelmeier C; Koczulla AR; Hohlfeld JM
J Breath Res; 2016 Apr; 10(2):026006. PubMed ID: 27082437
[TBL] [Abstract][Full Text] [Related]
18. Electronic nose technology for detection of invasive pulmonary aspergillosis in prolonged chemotherapy-induced neutropenia: a proof-of-principle study.
de Heer K; van der Schee MP; Zwinderman K; van den Berk IA; Visser CE; van Oers R; Sterk PJ
J Clin Microbiol; 2013 May; 51(5):1490-5. PubMed ID: 23467602
[TBL] [Abstract][Full Text] [Related]
19. Feasibility and diagnostic accuracy of an electronic nose in children with asthma and cystic fibrosis.
Bannier MAGE; van de Kant KDG; Jöbsis Q; Dompeling E
J Breath Res; 2019 May; 13(3):036009. PubMed ID: 30213921
[TBL] [Abstract][Full Text] [Related]
20. Exhaled volatile organic compounds analysis by e-nose can detect idiopathic pulmonary fibrosis.
Dragonieri S; Scioscia G; Quaranta VN; Carratu P; Venuti MP; Falcone M; Carpagnano GE; Foschino Barbaro MP; Resta O; Lacedonia D
J Breath Res; 2020 Jul; 14(4):047101. PubMed ID: 32320958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
